Synthesis, biological evaluation, and NMR studies of 3-fluorinated derivatives of 3’,4’,5’-trihydroxyflavone and 3’,4’,5’-trimethoxyflavone (2025)

. Author manuscript; available in PMC: 2022 Jan 15.

Published in final edited form as: Bioorg Med Chem Lett. 2020 Nov 28;32:127720. doi: 10.1016/j.bmcl.2020.127720

Maali D Alshammari

1, Pavel V Kucheryavy

1, Nicole M Ashpole

1, David A Colby

1

PMCID: PMC7785688NIHMSID: NIHMS1655644PMID: 33259925

The publisher's version of this article is available at Bioorg Med Chem Lett

Abstract

Flavones are valuable scaffolds in medicinal chemistry, especially as they display activity as antioxidants and neuroprotective agents. The need to incorporate a fluorine atom on flavones has driven much of the recent synthetic work in this area. We now report a route for the production of 3-fluorinated derivatives of 3’,4,’5-trihydroxyflavone and 3’,4’,5’-trimethoxyflavone. Biological evaluation of these agents, along with their non-fluorinated counterparts, demonstrate that antioxidant activity may be enhanced whereas neuroprotective activity is conserved. Also, the 3-fluoro-3’,4,’5-trihydroxyflavone can act as an NMR probe to detect structural changes during its action as a radical scavenger.

Keywords: flavone, fluorine, neuroprotection, antioxidant, NMR

Graphical Abstract

Synthesis, biological evaluation, and NMR studies of 3-fluorinated derivatives of 3’,4’,5’-trihydroxyflavone and 3’,4’,5’-trimethoxyflavone (1)

Introducing a fluorine atom into a biologically active molecule is a valuable approach in the process of drug discovery. This atom has a high electronegativity, a small size, and forms a strong bond with carbon, and these effects can improve the pharmacological and pharmacokinetic qualities of a lead structure.1,2 Flavones are secondary metabolites found in many fruits and vegetables, and these molecules display many biological activities, including action as antioxidants, which makes them a valuable scaffold in medicinal chemistry.3 Synthetic methods for the construction of fluorinated flavones have appeared from Fuchigami,4 Dolbier,5 Rozen,6 and Zhang,7 and all of these reports have focused on the incorporation of a fluorine atom at the 3-position of flavone.8 This position is the most difficult to access on the flavone skeleton, because all of the other sites can be modified by standard halogenation methods for substituted benzenes.

Flavones display a three-ring structure of 2-phenyl-4H-chromen-2-one and are labelled with A-, C-, and B-rings. Limited structure–activity data for fluorination of flavones have appeared in the literature and are summarized in Figure 1.911 The placement of fluorine at the 3-position of 3’,4’,7,8-tetrahydroxyflavone provides similar inhibition of telomerase activity compared to the non-fluorinated counterpart.9 Sale and coworkers created fluorinated derivatives at the 5-, 6-, and 7-positions of the flavonols, robinetin, myricetin, quercetin, kaempferol, and fisetin, and these modifications typically enhanced cytotoxicity against human prostate carcinoma (22Rv1) cells compared to the parent natural products.10 Flavonols are subclass of flavones that have a 3-hydroxy group. A synthetic derivative of the flavone, chrysin, with a 4’-fluorine displays a reduced rate of scavenging of reactive oxygen species of 55% compared to the natural product of 99%.11 These data provided the basis for this study to investigate the effects of fluorination on the anti-oxidant and neuroprotective activities of flavones.

Figure 1.

Open in a new tab

Our initial non-fluorinated targets were 3’,4’,5’-trimethoxyflavone (1) and 3’,4’,5’-trihydroxyflavone (2), because each acts as an antioxidant and serves as free radical scavenger in a DPPH assay.12,13 Flavone 1 was synthesized according to the route in the literature as shown in Figure 2.12 Briefly, 2-hydroxyacetophenone 3 and trimethoxybenzoyl chloride 4 were coupled in pyridine to give the ester 5 in 73% yield. Treatment of 5 with KOH in pyridine at 65 °C produced the 1,3-diketone 6 through a Baker-Venkataraman rearrangement. Cyclization of 6 by refluxing acetic acid and hydrochloric acid gave the 3’,4’,5’-trimethoxyflavone 1 in 71% yield.12 In order to improve this transformation, we found that iron(III) chloride in CH2Cl2 at rt promotes the cyclization of 6 to 1 in a higher yield of 89%.14 Finally, complete demethylation of 1 was achieved using hydrobromic acid at 100 °C and gave the 3’,4’,5’-trihydroxyflavone 2 in quantitative conversion.15

Figure 2.

Open in a new tab

The 3-fluoro-3’,4’,5’-trimethoxyflavone (7) is the 3-fluorinated counterpart of 1, and 7 has been synthesized10 but has not been tested for antioxidant activity. The 3-fluoro-3’,4’,5’-trihydroxyflavone (8) is not known in the literature, to our knowledge, and is the 3-fluorinated analogue of 2. Initially, fluoroflavone 7 was synthesized according to the route in the literature as shown in Figure 3.10 The fluorination of the 1,3-diketone 6 with NFSI in a solvent mixture of CH2Cl2 and CH3CN is known to produce the intermediate 9 in a low yield (i.e., 37%) after seven days. After additional investigations, we discovered that using pyridine as solvent and heating the mixture to 50 °C not only increased the yield to 72% but also decreased the reaction time from seven days to 12 h. The compound 9 is then cyclized in refluxing acetic acid with sulfuric acid or iron(III) chloride at rt to give the 3-fluoro-3’,4’,5’-trimethoxyflavone 7.16 During the course of our synthetic studies, we discovered that treating 6 with two equivalents of NFSI at rt for 12 h followed by heating the mixture to 80 °C for 12 h resulted in formation of 7 in 61% isolated yield. This one-pot transformation is more efficient than the two-step conversion of 6 to 9 and then 9 to 7. The fluoroflavone 7 is demethylated using hydrobromic acid at 100 °C to produce in quantitative yield the 3-fluoro-3’,4’,5’-trihydroxyflavone 8.17 The synthetic routes allowed the production of sufficient amounts of compounds for biological evaluation as antioxidants and neuroprotective agents.

Figure 3.

Open in a new tab

The DPPH assay is routinely used to characterize potential antioxidant activity, and the flavones 1, 2, 7, and 8 were tested in this assay to determine effects of radical scavenging (Table 1).18 Vitamin C (L-ascorbic acid) was used as the positive control, and a 1:1 solution of ethanol-acetone provided the optimal solubility for the flavones in assay. Serial dilutions of each of the test substrate were treated with DPPH (a stable free radical) across 20 minutes and then absorbance was measured. Six replicates were performed at each concentration, and EC50 values were calculated with the standard error. Flavones 1 and 2 displayed EC50 values (μg/mL) of 71 and 0.33, respectively, which are similar to reported values.12,13 The fluoroflavones 7 and 8 displayed improved activity as radical scavengers with EC50 values of 37 and 0.24, respectively. The results support that fluorination at the 3-position of the flavone scaffold may enhance antioxidant activity. These structure–activity data at the 3-position correlate well with the similar increases in potency in the telomerase assay observed by Menichincheri and coworkers.9 The trihydroxyflavone 2 and the 3-fluorinated trihydroxyflavone 8 display the most promising activity as antioxidants.

Table 1.

DPPH assay data for flavones 1, 2, 7 and 8.18

compdDPPH EC50 (μg/mL)a
vitamin C0.16 ± 0.03
171.66 ± 0.04
20.33 ± 0.01
737.14 ± 0.02
80.24 ± 0.04

Open in a new tab

a

Values are given with the standard error.

Flavones are currently investigated as source of potential neuroprotective agents, because new lead structures are needed for many neurodegenerative disorders.19 The flavones 1, 2, 7, and 8 were tested in oxidative glutamate toxicity assays with rat cortical neurons (Figure 4).20,21 The neurons were treated with glutamate in the presence of a test substrate and compared to the controls, DMSO and MK801 (GluN receptor antagonist). Glutamate provides an excitotoxic insult to the neurons, and the cells are incubated for 24 h before the addition of the MTS reagent used to evaluate cell viability. The production of formazan dye by viable neurons is measured, and the data were compared the controls to determine statistical significance using a one-way ANOVA with post hoc Dunnett’s test (Figure 4A). The trihydroxyflavone 2 and the 3-fluorinated trihydroxyflavone 8 display neuroprotective effects similar to MK801, and these data also correspond to the antioxidant activity in the DPPH assay. As glutamate excitation induces calcium imbalances and reactive oxygen stress that leads to neuronal death, the ability of these compounds to reduce reactive-oxygen species (ROS) generation in the presence of glutamate stimulation was assessed (Figure 4B). Test substrate (i.e., 1, 2, 7, or 8) was compared to the vehicle-control treated (DMSO) and glutamate-stimulated neurons. Only the 3-fluorinated trihydroxyflavone 8 reduces levels of ROS below baseline in the rat cortical neurons. These data suggest a potential beneficial effect for 3-fluorination when compared to the non-fluorinated counterpart 1 which only displays activity in the MTS assay.

Figure 4.

Open in a new tab

The scavenging of radical species by flavones is commonly attributed to the presence of hydroxyl groups on the ring B, which converts to an ortho-quinone during the process.22 Sawai and coworkers demonstrated that 13C NMR can observe the formation of the two carbonyl groups of this ortho-quinone intermediate upon the addition of DPPH to individual polyphenols present in tea leaves (Camellia sinesis).23, 24 Another report more recently recorded the formation of the ortho-quinone from phenolic acids treated with DPPH using 1H NMR.25 We investigated if an ortho-quinone intermediate could be observed from the fluoroflavone 8 following its quenching of free radicals. Accordingly, two equivalents of DPPH were added to a solution of fluoroflavone 8 in DMSO–d6 and 13C NMR data were acquired after 20 min (Figure 5). The appearance of three new carbonyl signals at 197, 194, and 193 ppm suggest that ring B of the flavone has changed in the process. The data from a DEPTQ135 analysis confirmed the quaternary nature of these carbon atoms.26 The carbonyl signal assigned to the 4-position of the flavone 8 (i.e., 169 ppm) also decreased in the 13C NMR, and it is important to note that none of the other peaks assigned to the parent flavone 8 disappeared following the addition of two equivalents of DPPH. In order to assign the new carbonyl peaks to the product, data was acquired by 1D selective HSQMBC NMR and verified that the carbonyl signals at 194 and 193 were on the same structure, which we assigned to the ortho-quinone.26 Additionaly, the experiment was analyzed by mass spectrometry (i.e., ESI–TOF), and three peaks were observed in the negative ion mode at 285.020, 287.028, and 287.036.26 The major peak at 287.036 is assigned to the starting material. The minor peak at 285.020 corresponds to the ortho-quinone, whereas the minor peak at 287.028 likely arises from a partially oxidized by-product. These data suggest that the ortho-quinone can form from 8, but there is not a complete conversion of the catechol into the quinone.

Figure 5.

Open in a new tab

These synthetic and mechanistic studies demonstrate the utility of fluorination of the 3-position on the flavone backbone. Antioxidant activity may be enhanced from this structural change whereas as neuroprotective activity is conserved. An improved synthetic route for the installation of the 3-fluorine was developed to ensure production of sufficient quantities for biological evaluation. NMR analysis of the 3-fluorinated flavone in the presence of a free radical source suggests that quenching occurs by conversion to the ortho-quinone. Future work is focused on enhancing the sensitivity of these probes for conducting mechanistic investigations on cultured neurons following the application of excitotoxins and will be reported in due course.

Supplementary Material

1

NIHMS1655644-supplement-1.pdf (614.7KB, pdf)

Highlights.

  • 3-Fluorinated flavones are created by a one-pot fluorination/cyclization

  • Flavones with 3-fluorination display antioxidant and neuroprotective activity

  • Structural changes of 3-fluorinated flavones from free radicals is observed by NMR

Acknowledgments

These studies were conducted with funding from the National Institute of Health (NIH) and the authors acknowledge National Institute of General Medical Sciences (P20GM104932 and P20GM130460). Fellowship support for M.D.A. was provided by the University of Hail, Saudi Arabia. The Bioanalytical Core of the GlyCORE at the University of Mississippi is also acknowledged for assistance with the acquisition of mass spectrometry data.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References and notes

  • 1.Meanwell NAJ. Med. Chem2018, 61, 5822–5880. [DOI] [PubMed] [Google Scholar]
  • 2.Gillis EP; Eastman KJ; Hill MD; Donnelly DJ; Meanwell NAJ. Med. Chem2015, 58, 8315–8359. [DOI] [PubMed] [Google Scholar]
  • 3.Singh M; Kaur M; Silakari OEur. J. Med. Chem2014, 84, 206–239. [DOI] [PubMed] [Google Scholar]
  • 4.Hou Y; Higashiya S; Fuchigami TJ. Org. Chem1999, 64, 3346–3349. [DOI] [PubMed] [Google Scholar]
  • 5.Médebielle M; Keirouz R; Okada E; Shibata D; Dolbier WRTetrahedron Lett. 2008, 49, 589–593. [Google Scholar]
  • 6.Vints I; Rozen SJ. Org. Chem2014, 79, 7261–7265. [DOI] [PubMed] [Google Scholar]
  • 7.Wang R; Han J; Li C; Zhang J; Liang Y; Wang T; Zhang ZOrg. Biomol. Chem2018, 16, 2479–2488. [DOI] [PubMed] [Google Scholar]
  • 8.For a review seeO’Leary EM; Jones DJ; O’Donovan FP; O’Sullivan TPJ. Fluorine Chem2015, 176, 93–120. [Google Scholar]
  • 9.Menichincheri M; Ballinari D; Bargiotti A; Bonomini L; Ceccarelli W; D’Alessio R; Fretta A; Moll J; Polucci P; Soncini C; Tibolla M; Trosset J-Y; Vanotti EJ. Med. Chem2004, 47, 6466–6475. [DOI] [PubMed] [Google Scholar]
  • 10.Britton RG; Horner-Glister E; Pomenya OA; Smith EE; Denton R; Jenkins PR; Steward WP; Brown K; Gescher A; Sale SEur. J. Med. Chem2012, 54, 952–958. [DOI] [PubMed] [Google Scholar]
  • 11.Chen Y-H; Yang Z-S; Wen C-C; Chang Y-S; Wang B-C; Hsiao C-A; Shih T-LFood Chem2012, 134, 717–724. [DOI] [PubMed] [Google Scholar]
  • 12.For the antioxidant activity and synthesis of 3’,4’,5’-trimethoxyflavone (1) see: Singh M; Kaur M; Vyas B; Silakari OMed. Chem. Res. 2018, 27, 520–530. [Google Scholar]
  • 13.For the antioxidant activity of 3’,4’,5’-trihydroxyflavone (2) see: Mahfoudi R; Djeridane A; Benarous K; Gaydou EM; Yousfi MBioorg. Chem2017, 74, 201–211. [DOI] [PubMed] [Google Scholar]
  • 14.Zubaidha PK; Hashmi AM; Bhosale RSHet. Commun2005, 11, 97–100. [Google Scholar]
  • 15.2-(3,4,5-Trihydroxyphenyl)-4H-chromen-4-one2: A mixture of 2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one 1 (10 mg, 0.03 mmol) in hydrobromic acid (1 mL) was heated in a sealed tube at 100 °C for 24 h. The reaction mixture was cooled to rt and concentrated under reduced pressure to afford the title compound (8.1 mg) in quantitative yield: mp 281–283 °C; 1H NMR (500 MHz, DMF-d6) δ 8.07 (dd, J = 7.9, 1.5 Hz, 1H), 7.83 (td, J = 7.9, 1.6 Hz, 1H), 7.50 (t, J = 7.4 Hz, 1H), 7.17 (s, 2H), 6.68 (s, 1H), 5.76 (br s, 3H); 13C NMR (100 MHz, DMSO–d6) δ 176.9, 163.7, 155.6, 146.5 (2C), 137.8, 134.2, 125.4, 124.8, 123.4, 120.8, 118.4, 105.8 (2C), 104.9; IR (film) νmax 3448, 1639, 1590, 1037 cm−1; HRMS (ESI–TOF) m/z calcd for C15H9O5 (M–H) 269.0450, found 269.0432. All characterization data were identical with the reported data in:; Hiza A; Tsukaguchi Y; Ogawa T; Inai M; Asakawa T; Hamashima Y; Kan THeterocycles2014, 88, 1371–1396. [Google Scholar]
  • 16.3-Fluoro-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one7: Method 1: A mixture of (E)-2-fluoro-3-hydroxy-1-(2-hydroxyphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 5 (10 mg, 0.03 mmol), and iron(III) chloride (0.47 mg, 0.009 mmol) in dichloromethane (1 mL) was stirred at rt for 24 h. The reaction mixture was extracted with CH2Cl2 (1 mL × 3). The organics were dried over Na2SO4 and concentrated under reduced pressure to afford the title compound 7 as a yellow solid (7.9 mg) in 84% yield. Method 2: A mixture of 6 (176.7 mg, 0.53 mmol), and N-fluorobenzenesulfonimide (340 mg, 1.06 mmol) in pyridine (4 mL) was stirred at rt for 12 h, then heated to 80 °C for 12 h. The reaction mixture was cooled to rt and water (2 mL) was added. Then, the mixture was cooled to 0 °C and acidified with 2.0 M of aqueous HCl (3 mL). The resultant mixture was extracted with EtOAc (6 mL × 3). The organics were dried over Na2SO4 and concentrated under reduced pressure. Silica and neutral alumina (1:1 SiO2 /Al2O3) flash chromatography (7:3 hexanes/EtOAc) afforded the title compound 7 as a yellow solid (108 mg) in 61% yield: mp 175–176 °C; 1H NMR (400 MHz, CDCl3) δ 8.26 (d, J = 8.1 Hz, 1H), 7.71 (t, J = 7.0 Hz, 1H), 7.58 (d, J = 8.3 Hz, 1H), 7.42 (t, J = 7.5 Hz, 1H), 7.24 (s, 2H), 3.94 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 170.7 (d, JCF = 16.9 Hz, 1C), 154.9, 153.3 (2C), 150.6 (d, JCF = 23.1 Hz, 1C), 145.9 (d, J = 248.0 Hz, 1C), 141.0 (d, JCF = 1.8 Hz, 1C), 133.9, 125.8, 125.1, 124.1 (d, JCF = 7.0 Hz, 1C), 123.7 (d, JCF = 5.1 Hz, 1C), 118.1, 105.6 (d, JCF = 8.4 Hz, 2C), 61.0, 56.3 (2C); 19F NMR (470 MHz, CDCl3) –161.31; IR (film) νmax 1725, 1685, 1036 cm−1; HRMS (ESI–TOF) m/z calcd for C18H15FO5Cs (M+Cs)+ 462.9958, found 462.9949. All characterization data were identical with the reported data in Ref 10.
  • 17.3-Fluoro-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one8: A mixture of 7 (10 mg, 0.03 mmol) in hydrobromic acid (1 mL) was heated in a sealed tube at 100 °C for 24 h. The reaction mixture was cooled to rt and concentrated under reduced pressure to afford the title compound as a yellow solid (8.6 mg) in quantitative yield: mp 280–282 °C; 1H NMR (500 MHz, DMSO-d6) δ 8.11 (dd, J = 8.0, 1.7 Hz, 1H), 7.86 (t, J = 7.5 Hz, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.53 (t, J = 7.5 Hz, 1H), 7.07 (s, 2H), 4.12 (br s, 3H); 13C NMR (100 MHz, DMSO-d6) δ 169.4 (d, JCF = 16.1 Hz, 1C), 154.5, 151.2 (d, JCF = 23.1 Hz, 1C), 146.2 (2C), 145.1 (d, JCF = 242.0 Hz, 1C), 137.5, 134.4, 125.3, 124.9 (d, JCF = 3.3 Hz, 1C), 123.6 (d, JCF = 7.0 Hz, 1C), 118.4, 117.8 (d, JCF = 5.1 Hz, 1C), 107.4 (d, JCF = 8.1 Hz, 2C); 19F NMR (376 MHz, DMSO-d6) δ –165.2; IR (film) νmax 3655, 1685, 1646, 1037 cm−1; HRMS (ESI–TOF) m/z calcd for C15H9FO5 (M) 287.0356, found 287.0360.
  • 18.DPPH assay. The assay measures the presence of the DPPH (2,2-diphenyl-1-picrylhydrazyl) radical, which is a stable radical with an absorbance between 515–528 nm. Stock solutions of test compounds were prepared at 1 mg/mL in 1:1 ethanol-acetone and a 0.2 M solution of DPPH in the same solvent system was also made. All solutions were stored at 3 °C in the dark. Serial dilutions of 100 μL of the test compound were added to a 96-well plate, and six replicates were prepared for each dilution. Next, the dilutions were treated with 100 μL of the DPPH stock solution, and the plate was incubated at rt in the dark for 20 min. Absorbance was measured at 517 nm. Vitamin C (ascorbic acid) was the positive control. The antioxidant activity of the flavones is expressed as an EC50 value (with the standard error) defined by the concentration in μg/mL that inhibits the formation of DPPH radicals by 50%.
  • 19.Ayaz M; Sadiq A; Junaid M; Ullah F; Ovais M; Ullah I; Ahmed J; Shahid MFront. Aging Neurosci2019, 11, 155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ashpole NM; Hudmon AMol. Cell. Neurosci2011, 46, 720–730. [DOI] [PubMed] [Google Scholar]
  • 21.Neuroprotective assay. The 96-well plates were coated with 60 μL of 0.01% poly-L-lysine, incubated for 24 h, and then washed with distilled water. Sprague-Dawley rat cortical neurons were harvested and cultured for 24 h in a 96-well plate with 100 μL growth media that includes neurobasal media, L-glutamine, fetal bovine serum (FBS), and pen strep. Next, the growth media was replaced with media that does not contain FBS, and the plate was further incubated for one week. The assay is performed with 8–10 day old rat cortical neurons, and the cultures are pre-treated with varying concentrations of test compound for 1 h before the application of glutamate in a concentration-dependent manner as an excitotoxic insult. After incubation for 24 h, MTS (aqueous one solution) reagent is added, and the plates are returned to the incubator for 1 h. The formazan dye is produced by viable neurons and is quantified by measuring absorbance at 490 nm. Total cell number is also assessed using microscopy. Then, the data are compared to DMSO and the glutamate receptor antagonist, MK801, as controls to determine statistical significance using a one-way ANOVA with post hoc Dunnetťs test. A second set of neurons was treated with test compound and glutamate stimulation for 1 hr and then loaded and incubated with 5 micromolar H2-DCFDA (2’,7’-dichlorofluorescin diacetate) in PBS for 60 minutes (per manufacturer recommendations, ThermoFisher). DCFDA fluorescence was quantified on the microplate reader with 495/520 excitation/emission.
  • 22.Pietta P-GJNat. Prod2000, 63, 1035–1042. [DOI] [PubMed] [Google Scholar]
  • 23.Sawai Y; Moon J-H; Sakata K; Watanabe NJ. Agric. Food Chem2005, 53, 3598–3604. [DOI] [PubMed] [Google Scholar]
  • 24.Sawai Y; Moon J-HJ. Agric. Food Chem2000, 48, 6247–6253. [DOI] [PubMed] [Google Scholar]
  • 25.Lopez-Martinez LM; Santacruz-Ortega H; Navarro R-E; Sotelo-Munod RR; Gonzalez-Aquilar GAPLOS One2015, 10, e0140242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.See Supplementary Material for details.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

NIHMS1655644-supplement-1.pdf (614.7KB, pdf)

Synthesis, biological evaluation, and NMR studies of 3-fluorinated derivatives of 3’,4’,5’-trihydroxyflavone and 3’,4’,5’-trimethoxyflavone (2025)

References

Top Articles
Latest Posts
Recommended Articles
Article information

Author: Greg Kuvalis

Last Updated:

Views: 5985

Rating: 4.4 / 5 (75 voted)

Reviews: 90% of readers found this page helpful

Author information

Name: Greg Kuvalis

Birthday: 1996-12-20

Address: 53157 Trantow Inlet, Townemouth, FL 92564-0267

Phone: +68218650356656

Job: IT Representative

Hobby: Knitting, Amateur radio, Skiing, Running, Mountain biking, Slacklining, Electronics

Introduction: My name is Greg Kuvalis, I am a witty, spotless, beautiful, charming, delightful, thankful, beautiful person who loves writing and wants to share my knowledge and understanding with you.